Trenarthan worked with a pharmaceutical joint venture whose members included Baxter Healthcare, Bayer and Aventis Behring to locate innovative research projects throughout the world. We built and implemented an effective approach on a country-by-country basis, locating potential projects at academic and industrial centers of excellence around the world. The joint venture was seeking the best available science to improve the safety of their biological products. Our efforts produced a significant number of opportunities in Europe and Asia and resulted in agreements to fund and license technologies with institutions in, among other places, England, France, Switzerland and Scotland.
|